West Pharmaceutical Services Inc. (WST) Social Stream
WEST PHARMACEUTICAL SERVICES INC (WST) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering WEST PHARMACEUTICAL SERVICES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 5 | $515 | $400 | $448.75 | $328.94 | 36.42% |
| 2022-02-18 | 4 | $515 | $405 | $455 | $328.94 | 38.32% |
| 2022-03-01 | 5 | $475 | $400 | $438.75 | $328.94 | 33.38% |
| 2022-04-28 | 5 | $475 | $400 | $420 | $328.94 | 27.68% |
| 2022-04-29 | 5 | $410 | $400 | $403.75 | $328.94 | 22.74% |
| 2022-05-09 | 5 | $410 | $341 | $387.75 | $328.94 | 17.88% |
| 2022-06-06 | 5 | $410 | $341 | $380.25 | $328.94 | 15.6% |
| 2022-07-28 | 5 | $410 | $333 | $378.25 | $328.94 | 14.99% |
| 2022-08-13 | 5 | $400 | $330 | $361.25 | $328.94 | 9.82% |
| 2022-10-17 | 4 | $400 | $330 | $365 | $328.94 | 10.96% |
| 2022-10-27 | 4 | $385 | $330 | $352.5 | $328.94 | 7.16% |
| 2022-10-28 | 3 | $350 | $206 | $287.75 | $328.94 | -12.52% |
| 2022-11-01 | 6 | $350 | $206 | $272.75 | $328.94 | -17.08% |
| 2022-12-02 | 6 | $315 | $206 | $261.2 | $328.94 | -20.59% |
| 2023-01-06 | 7 | $315 | $206 | $252.666 | $328.94 | -23.19% |
| 2023-01-26 | 7 | $315 | $240 | $258.333 | $328.94 | -21.47% |
| 2023-02-09 | 7 | $315 | $240 | $260 | $328.94 | -20.96% |
| 2023-02-16 | 7 | $375 | $240 | $270 | $328.94 | -17.92% |
| 2023-02-17 | 7 | $375 | $250 | $294.166 | $328.94 | -10.57% |
| 2023-02-23 | 7 | $375 | $250 | $300.833 | $328.94 | -8.54% |
| 2023-03-01 | 7 | $375 | $250 | $313.333 | $328.94 | -4.74% |
The Trend in the Analyst Price Target
WST's average price target has moved down $109.67 over the prior 18 months.
Over the past 44 weeks, WST's average upside potential has been 14.09%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-29 | 5 | 410 | 400 | 403.750 | 315.06 | 28.15% |
| 2022-07-28 | 5 | 410 | 333 | 378.250 | 339.92 | 11.28% |
| 2022-10-28 | 5 | 350 | 250 | 318.750 | 225.51 | 41.35% |
| 2022-12-14 | 7 | 315 | 206 | 252.666 | 243.58 | 3.73% |
| 2022-12-15 | 7 | 315 | 206 | 252.666 | 237.08 | 6.57% |
WST Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.43 | 2 | 0 | 5 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 48 weeks, WST's average broker recommendation rating worsened by 0.63.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, WEST PHARMACEUTICAL SERVICES INC's average analyst price target is higher than 2774.2% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, WEST PHARMACEUTICAL SERVICES INC's number of analysts covering the stock is higher than 191.05% of them.
- WST has a greater upside potential (average analyst target price relative to current price) than 326.28% of Healthcare stocks.
- WEST PHARMACEUTICAL SERVICES INC's variance in analysts' estimates is lower than -592.71% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Rubber and Plastic Products industry with the ratings most similar to WEST PHARMACEUTICAL SERVICES INC are WMS, BERY, and ENTG.
View All Top Stocks by Price Target
What is the outlook for WST? Use POWR Ratings for clearer insight into price direction.